Cloning and expression in Escherichia coli of a human gelatinase B-inhibitory single-chain immunoglobulin variable fragment (scFv)

FEBS Letters

Volumn 414, Issue 3, 1997, Pages 562-566

  Zhou, Naiming ^a   Paemen, Liesbet ^a   Opdenakker, Ghislain ^a   Froyen, Guy ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Gelatinase B; Matrix metalloproteinase; Monoclonal antibody; Single chain variable fragment

Indexed keywords

COMPLEMENTARY DNA; ENZYME ANTIBODY; GELATINASE B; IMMUNOGLOBULIN FRAGMENT; MYC PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; ESCHERICHIA COLI; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; HUMAN CELL; HYBRIDOMA; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; COLLAGENASES; ESCHERICHIA COLI; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; MATRIX METALLOPROTEINASE 9; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS;

ESCHERICHIA COLI; MURINAE;

EID: 0030755243     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)01072-7     Document Type: Article

References (25)

1. Crawford H.C., Matrisian L.M. Invasion Metastasis. 14:1995;234-245.
2. Mignatti P., Rifkin D.B. Physiol. Rev. 73:1993;161-195.
3. Opdenakker G., Van Damme J. Immunol. Today. 15:1994;103-106.
4. Opdenakker G., Van Damme J. Cytokine. 4:1992;251-258.
5. Bernhard E.J., Muschel R.J., Hughes E.N. Cancer Res. 50:1990;3872-3877.
6. Opdenakker G., Masure S., Grillet B., Van Damme J. Lymphokine Cytokine Res. 10:1991;317-324.
7. Paemen L., Olsson T., Söderstrom M., Van Damme J., Opdenakker G. Eur. J. Neurol. 1:1994;55-63.
8. McMillan J.I., Weeks R., West J.W., Bursten S., Rice G.C., Lovett D.M. Int. J. Cancer. 67:1996;523-531.
9. Cuzner M.L., Gveric D., Strand C., Loughlin A.J., Paemen L., Opdenakker G., Newcombe J. J. Neuropathol. Exp. Neurol. 55:1996;1194-1204.
10. Gijbels K., Galardy R.E., Steinman L. J. Clin. Invest. 94:1994;2177-2182.
11. Hewson A.K., Smith T.S., Leonard J.P., Cuzner M.L. Inflamm. Res. 44:1995;345-349.
12. Naito K., Kanbayashi N., Nakajima S., Murai T., Arakawa K., Nishimura S., Okuyama A. Int. J. Cancer. 58:1994;730-735.
13. Paemen L., Martens E., Norga K., Masure S., Roets E., Hoogmartens J., Opdenakker G. Biochem. Pharmacol. 52:1996;105-111.
14. Paemen L., Martens E., Masure S., Opdenakker G. Eur. J. Biochem. 234:1995;759-765.
15. Pimm M.V., Durrant L.G., Baldwin R.W. Int. J. Cancer. 43:1989;147-151.
16. Mendez M.J., Green L.L., Corvalan J.R.F., et al. Nature Med. 15:1997;146-156.
17. Hoogenboom H.R., Winter G. J. Mol. Biol. 227:1992;381-388.
18. Froyen G., Ronsse I., Billiau A. Mol. Immunol. 30:1993;805-812.
19. Orlandi R., Güssow D.H., Jones P.T., Winter G. Proc. Natl. Acad. Sci. USA. 86:1989;3833-3837.
20. Skerra A., Plückthun A. Science. 240:1988;1038-1041.
21. Laemmli U.K. Nature. 227:1970;680-685.
22. Bradford M.M. Anal. Biochem. 72:1975;241-245.
23. Masure S., Proost P., Van Damme J., Opdenakker G. Eur. J. Biochem. 198:1991;391-398.
24. Kabat, E.A., Wu, T.T., Reid-Miller, M., Perry, H.M. and Gottesman, K.S. (1987) Sequences of Proteins of Immunological Interest, U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD.
25. Glockshüber R., Malia M., Pfitzinger I., Plückthun A. Biochemistry. 29:1990;1362-1367.